Search

everythinglearnresearchcommunity

for

Search:↓

The combination of high-dose toremifene and capecitabine was effective for advanced recurrent breast cancer.

A 10-month-old boy with a rare combination of genetic conditions has severe immune deficiency and treatment challenges.

A man's hair loss was linked to his HIV medication, which improved after changing drugs.

Bortezomib chemotherapy can cause temporary skin rashes.

Deucravacitinib helped a man regrow hair significantly.

Gene therapy with a vitamin D receptor gene improved hair growth in rats with a type of rickets-related baldness.

Bexxar is highly effective as a first treatment for non-Hodgkin's lymphoma, with most patients alive and many in remission after eight years.

Biotin supplements did not significantly reduce hair loss in rats on valproic acid.

Low dose valproic acid treatment caused hair loss in a young patient.

Capivasertib improves survival in certain breast cancer cases but requires careful management of side effects.

The FDA approved the first gene therapy for a blood disorder after overcoming early challenges and demonstrating patient benefits.

Partial hair-sparing brain radiotherapy is possible and doesn't affect cancer control but still causes noticeable hair loss.

Chemotherapy caused nail grooves and separation, but they healed after treatment stopped.

Alopecia can be reversed with timely steroid treatment in VKH and SO diseases.

A woman's total hair loss from hepatitis C treatment grew back after stopping the medication.

Vogt-Koyanagi-Harada disease affects vision and skin, mainly in people with darker skin, and is treated with steroids and immunosuppressants.

Deucravacitinib helped a man regrow hair and improve psoriasis.

Abemaciclib can cause skin, hair, and nail problems, leading some patients to stop using it.

New butyric acid prodrugs show promise for cancer treatment, anemia management, and protecting hair from chemotherapy damage.

Tavaborole is a safe and effective toenail fungus treatment, with the 5% solution being the best option.

Both VEPA and ML-Y1 treatments are not effective enough for elderly non-Hodgkin's lymphoma patients.

A woman's hair loss during treatment with specific hepatitis C drugs grew back after stopping the medication.

VDDR I and II are genetic disorders affecting vitamin D use, causing rickets, with VDDR I treatable by vitamin D supplements and VDDR II needing high doses and calcium.

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

VLDL could be an early warning sign for male pattern baldness.

Eflornithine improved symptoms in Bachmann–Bupp Syndrome patients.

VKHD can include rare oral symptoms like discolored teeth.

A new drug, abrocitinib, helped a child with severe hair loss regrow hair.

Dabrafenib was effective and well tolerated in treating thyroid cancer with a specific mutation.